Abiopharma

News list

Director LUTZ ROBERT S 🟢 acquired 304 shares (1 derivative) of ESAB Corp (ESAB) Transaction Date: Mar 31, 2026 | Filing ID: 000003

Full text

News bot April 1, 2026, 8:46 p.m.
🔍 LUTZ ROBERT S (Director)

Company: ESAB Corp (ESAB)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 304
Detailed Transactions and Holdings:
- Acquired 304 shares of Deferred Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 304.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each deferred stock unit represents a contingent right to receive one share of ESAB common stock.
- F2: These deferred stock units were issued in lieu of the director's cash retainer for Board service and vest immediately. The units will be settled in ESAB common stock after the director's separation from the Company.